170 related articles for article (PubMed ID: 20367804)
21. Analysis of hepatitis C virus core encoding sequences in chronically infected patients reveals mutability, predominance, genetic history and potential impact on therapy of Cuban genotype 1b isolates.
González-Horta EE; Marante J; Amador-Cañizares Y; Alvarez-Lajonchere L; Guerra I; Martínez-Donato G; Dueñas-Carrera S
Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1320-7. PubMed ID: 22195367
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
[TBL] [Abstract][Full Text] [Related]
23. Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.
Welker MW; von Wagner M; Ochs D; Zimmer V; Hofmann WP; Piiper A; Hartmann RW; Herrmann E; Zeuzem S; Kronenberger B
Dig Liver Dis; 2010 Oct; 42(10):735-40. PubMed ID: 20457015
[TBL] [Abstract][Full Text] [Related]
24. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
Kimura Y; Hayashida K; Ishibashi H; Niho Y; Yanagi Y
J Med Virol; 2000 May; 61(1):37-43. PubMed ID: 10745230
[TBL] [Abstract][Full Text] [Related]
25. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
26. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: no correlation with viral genotypes 1b, 2a, and 2b.
Kao JH; Chen PJ; Lai MY; Wang TH; Chen DS
J Med Virol; 1997 Jul; 52(3):270-4. PubMed ID: 9210035
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
Castillo I; Rodríguez-Iñigo E; Bartolomé J; de Lucas S; Ortíz-Movilla N; López-Alcorocho JM; Pardo M; Carreño V
Gut; 2005 May; 54(5):682-5. PubMed ID: 15831916
[TBL] [Abstract][Full Text] [Related]
28. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
29. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease.
Bokharaei-Salim F; Keyvani H; Monavari SH; Alavian SM; Madjd Z; Toosi MN; Mohammad Alizadeh AH
J Med Virol; 2011 Jun; 83(6):989-95. PubMed ID: 21503911
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain.
Sherman KE; Andreatta C; O'Brien J; Gutierrez A; Harris R
Hepatology; 1996 Apr; 23(4):688-94. PubMed ID: 8666318
[TBL] [Abstract][Full Text] [Related]
32. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
[TBL] [Abstract][Full Text] [Related]
33. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
34. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
Nakazawa T; Hijikata M; Kato N; Shimotohno K
Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
[TBL] [Abstract][Full Text] [Related]
35. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
[TBL] [Abstract][Full Text] [Related]
37. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
38. CD81 sequence and susceptibility to hepatitis C infection.
Houldsworth A; Metzner MM; Demaine A; Hodgkinson A; Kaminski E; Cramp M
J Med Virol; 2014 Jan; 86(1):162-8. PubMed ID: 24122777
[TBL] [Abstract][Full Text] [Related]
39. New evidence of replication of hepatitis C virus in short-term peripheral blood mononuclear cell cultures.
Di Lello FA; Culasso AC; Parodi C; Baré P; Campos RH; García G
Virus Res; 2014 Oct; 191():1-9. PubMed ID: 25087877
[TBL] [Abstract][Full Text] [Related]
40. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
